Category: Biosimilars
Global Biosimilars
-
Global Biologics and Biosimilars Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a ... Read More
-
Biosimilars Market based on by Material Type (Silicon, Germanium, Transition Metal Oxides, Gold), Industry (Consumer Electronics, Automotive, Aviation, Energy, Medical Devices), Regional Outlook– Global Forecast up to 2032
... a high priority on the development of biosimilars. By December 2022, 25 biosimilars had been introduced in the US and 40 had received FDA approval. FDA approvals fell off dramatically during the COVID-19 pandemic, but ... Read More
-
Aseptic Connectors Market - A Global and Regional Analysis: Focus on Type, Product, End User and Region - Analysis and Forecast, 2023-2033
... at $746.7 million in 2023 and is expected to reach $1,907.0 million by 2033, growing at a CAGR of 9.83% between 2023 and 2033. The global aseptic connectors market is a dynamic and rapidly evolving ... Read More
-
2024 Global: Biosimilars Market - Innovative Markets Forecast (2030) report
... 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression analysis in ... Read More
-
2024 Global: Biosimilar Monoclonal Antibodies Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
2024 Global Forecast for Bioprocess Containers Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx billion ... Read More
-
Traumatic Brain Injury Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Acetylcholinesterase Inhibitors, Erythropoietin, Growth Hormone, Stem Cells, Others), By Application (Local TBI, Open TBI, Closed TBI, Diffuse TBI, Primary TBI, Others), by Region, Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global Traumatic Brain Injury Therapeutics market size is poised to register 5.56% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
mAb Biosimilars Market Size, Trends, Analysis, and Outlook By Type (Adalimumab, Bevacizumab, Infliximab, Rituximab, Trastuzumab, Others), By Indication (Oncology, Autoimmune diseases, Others), By End-User (Hospitals, Cancer Treatment centers, Others), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global mAb Biosimilars market size is poised to register 8.8% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global mAb ... Read More
-
Global Glycosylated Biosimilars Market Growth (Status and Outlook) 2024-2030
... market, the Glycosylated Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Glycosylated Biosimilars ... Read More
-
Global Peptides Biosimilars Market Growth (Status and Outlook) 2024-2030
... market, the Peptides Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Peptides Biosimilars ... Read More
-
Global Recombinant Non-Glycosylated Proteins Biosimilars Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Recombinant Non-Glycosylated Proteins Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Biosimilars & Follow-on-Biologics Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Biosimilars & Follow-on-Biologics is forecast to a readjusted size of US$ 60550 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential ... Read More
-
Global Retinal Biosimilars Market Growth (Status and Outlook) 2024-2030
... market, the Retinal Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Retinal Biosimilars ... Read More
-
Global Pen Needles Market - 2024-2031
... period 2024-2031. The global pen needles market witnessed rise in demand as an increasing number of diabetes patients in which insulins are commonly used. Manufacturers introduce various innovative features such as ultra-thin needles, enhanced safety ... Read More
-
Global Monoclonal antibodies (mAbs) Biosimilars Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... market growth of the Monoclonal antibodies (mAbs) Biosimilars industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Monoclonal antibodies (mAbs) Biosimilars. The report ... Read More
-
Gastrointestinal Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, Others), By Route of Administration (Oral, Injectable, Others), By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Gastrointestinal Therapeutics market size is poised to register ... Read More
-
Opioid-Induced Constipation Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, Others), By Route of Administration (Oral, Injectable, Others), By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Opioid-Induced Constipation market size is poised to register ... Read More
-
Global Erythropoietin (EPO) Drugs Market Growth 2024-2030
... market, the Erythropoietin (EPO) Drugs is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.4% during review period. The research report highlights the growth potential of the global ... Read More
-
Generic Pharmaceuticals Market Size, Trends, Analysis, and Outlook By Type (Simple Generics, Specialty Generics, Biosimilar), By Application (Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases, Cancer, Diabetes, Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Generic Pharmaceuticals ... Read More
-
The 2025-2030 World Outlook for Biosimilars and Related Biologics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilars
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies (mAb)
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilar Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Recombinant Non-Glycosylated Protein Biosimilars
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Immunology Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
Research Assistance
